Erratum
In the November 2006 issue, the competing interests statement of the authors of this Review was omitted. The competing interests statement should have appeared as “N Nishimoto declared associations with the following company: Chugai Pharmaceutical. T Kishimoto holds a patent for tocilizumab. See the article online for further details of these competing interests.”
Additional information
The online version of the original article can be found at 10.1038/ncprheum0338
Rights and permissions
About this article
Cite this article
Nishimoto, N., Kishimoto, T. Erratum: Interleukin 6: from bench to bedside. Nat Rev Rheumatol 2, 691 (2006). https://doi.org/10.1038/ncprheum0372
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0372
